BACKGROUND: Approximately half of epithelial ovarian cancers are fatal within 3 years; however, roughly 35% of women survive for at least 10 years. In the Nurses' Health Study, New England Case-Control Study, Australian Ovarian Cancer Study, and NIH-AARP Diet and Health Study, we investigated potential differences in the associations with ovarian cancer risk factors by tumor aggressiveness, defined on the basis of time from diagnosis until death. METHODS: We calculated relative risks (RR) and 95% confidence intervals (CI) for associations of known or suspected ovarian cancer risk factors with rapidly fatal (death within 3 years of diagnosis) and less aggressive tumors (all others) using Cox proportional hazards competing risks analysis (NHS and AARP) or polytomous logistic regression (NECC, AOCS). Results were combined using random effects meta-analysis. RESULTS: Increasing age was associated with greater risk of rapidly fatal versus less aggressive disease (RR, 5-year increase: 1.39; 95% CI, 1.29-1.49 vs. RR, 1.09; 95% CI, 1.03-1.16, respectively; Pdiff < 0.0001). Oral contraceptive use was associated with a greater decreased risk of rapidly fatal (RR, 5-year increase: 0.69; 95% CI, 0.58-0.82) versus less aggressive disease (RR, 0.81; 95% CI, 0.74-0.89; Pdiff, 0.002). Conversely, increasing parity was associated only with less aggressive disease (RR per child, 0.87; 95% CI, 0.81-0.93). CONCLUSION: In this analysis of 4,342 cases, there were clear differences in risk factors for rapidly fatal versus less aggressive ovarian tumors. IMPACT: Differences in risk factor associations by tumor aggressiveness suggests the developmental pathways through which the tumors develop and may be important for developing primary preventive strategies for the most aggressive cancers.
BACKGROUND: Approximately half of epithelial ovarian cancers are fatal within 3 years; however, roughly 35% of women survive for at least 10 years. In the Nurses' Health Study, New England Case-Control Study, Australian Ovarian Cancer Study, and NIH-AARP Diet and Health Study, we investigated potential differences in the associations with ovarian cancer risk factors by tumor aggressiveness, defined on the basis of time from diagnosis until death. METHODS: We calculated relative risks (RR) and 95% confidence intervals (CI) for associations of known or suspected ovarian cancer risk factors with rapidly fatal (death within 3 years of diagnosis) and less aggressive tumors (all others) using Cox proportional hazards competing risks analysis (NHS and AARP) or polytomous logistic regression (NECC, AOCS). Results were combined using random effects meta-analysis. RESULTS: Increasing age was associated with greater risk of rapidly fatal versus less aggressive disease (RR, 5-year increase: 1.39; 95% CI, 1.29-1.49 vs. RR, 1.09; 95% CI, 1.03-1.16, respectively; Pdiff < 0.0001). Oral contraceptive use was associated with a greater decreased risk of rapidly fatal (RR, 5-year increase: 0.69; 95% CI, 0.58-0.82) versus less aggressive disease (RR, 0.81; 95% CI, 0.74-0.89; Pdiff, 0.002). Conversely, increasing parity was associated only with less aggressive disease (RR per child, 0.87; 95% CI, 0.81-0.93). CONCLUSION: In this analysis of 4,342 cases, there were clear differences in risk factors for rapidly fatal versus less aggressive ovarian tumors. IMPACT: Differences in risk factor associations by tumor aggressiveness suggests the developmental pathways through which the tumors develop and may be important for developing primary preventive strategies for the most aggressive cancers.
Authors: D C Whiteman; M F Murphy; L S Cook; D W Cramer; P Hartge; P A Marchbanks; P C Nasca; R B Ness; D M Purdie; H A Risch Journal: J Natl Cancer Inst Date: 2000-07-19 Impact factor: 13.506
Authors: Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen Journal: Int J Cancer Date: 2011-11-10 Impact factor: 7.396
Authors: Bernard Rosner; Robert J Glynn; Rulla M Tamimi; Wendy Y Chen; Graham A Colditz; Walter C Willett; Susan E Hankinson Journal: Am J Epidemiol Date: 2013-05-03 Impact factor: 4.897
Authors: Nonna V Kolomeyevskaya; J Brian Szender; Gary Zirpoli; Albina Minlikeeva; Grace Friel; Rikki A Cannioto; Rachel M Brightwell; Kassondra S Grzankowski; Kirsten B Moysich Journal: Int J Gynecol Cancer Date: 2015-11 Impact factor: 3.437
Authors: Tianyi Huang; Shelley S Tworoger; Jonathan L Hecht; Megan S Rice; Anil K Sood; Laura D Kubzansky; Elizabeth M Poole Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-09-01 Impact factor: 4.254
Authors: Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry Journal: Cancer Causes Control Date: 2014-09-05 Impact factor: 2.506
Authors: Marta Szajnik; Magdalena Derbis; Michal Lach; Paulina Patalas; Marcin Michalak; Hanna Drzewiecka; Dariusz Szpurek; Andrzej Nowakowski; Marek Spaczynski; Włodzimierz Baranowski; Theresa L Whiteside Journal: Gynecol Obstet (Sunnyvale) Date: 2013-04-29
Authors: Molin Wang; Donna Spiegelman; Aya Kuchiba; Paul Lochhead; Sehee Kim; Andrew T Chan; Elizabeth M Poole; Rulla Tamimi; Shelley S Tworoger; Edward Giovannucci; Bernard Rosner; Shuji Ogino Journal: Stat Med Date: 2015-12-01 Impact factor: 2.373
Authors: Shilpa N Bhupathiraju; Francine Grodstein; Meir J Stampfer; Walter C Willett; Frank B Hu; JoAnn E Manson Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308
Authors: Elizabeth M Poole; I-Min Lee; Paul M Ridker; Julie E Buring; Susan E Hankinson; Shelley S Tworoger Journal: Am J Epidemiol Date: 2013-08-21 Impact factor: 4.897
Authors: Tianyi Huang; Elizabeth M Poole; A Heather Eliassen; Olivia I Okereke; Laura D Kubzansky; Anil K Sood; John P Forman; Shelley S Tworoger Journal: Int J Cancer Date: 2016-03-25 Impact factor: 7.396
Authors: Melissa A Merritt; Elizabeth M Poole; Susan E Hankinson; Walter C Willett; Shelley S Tworoger Journal: Cancer Causes Control Date: 2014-04-11 Impact factor: 2.506